ArticleBMJ open2023

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.

Mark A Hull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.